Rss Feed
Tweeter button
Facebook button
Reddit button
Myspace button
Linkedin button
Delicious button
Digg button
Jul 02

J&J buys $1 billion Elan stake, gains Alzheimer’s R&D

Finance | Add comments

LONDON/BOSTON (Reuters) – Johnson & Johnson has agreed to pay $1 billion for an 18.4 percent stake in Irish drugmaker Elan Corp, and will acquire most of the rights to Elan’s portfolio of experimental drugs to treat Alzheimer’s disease.

Share This Post

Post to Twitter

Leave a Reply

You must be logged in to post a comment.

preload preload preload